Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Treatment of Burn Wounds With Various Antimicrobial Topical Soaks
This study has been terminated.

First Received on December 26, 2007.   Last Updated on December 6, 2011   History of Changes
Sponsor: The University of Texas, Galveston
Information provided by (Responsible Party): The University of Texas, Galveston
ClinicalTrials.gov Identifier: NCT00675922
  Purpose

Determine effectiveness of various antimicrobial solutions on burn wounds (infections, wound healing, length of hospital stay).


Condition Intervention Phase
Burn
Drug: Sulfamylon Solution 5%
Drug: Dakins 0.025% solution
Drug: Cerium solution
Drug: Silver Nitrate
Phase II
Phase III

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Comparing the Use of Sulfamylon 5%, Dakins 0.025%, Cerium, Silver Nitrate 5% and/or Other Topical Antimicrobial Products for the Treatment of Excised and/or Grafted Burn Wounds

Resource links provided by NLM:


Further study details as provided by The University of Texas, Galveston:

Primary Outcome Measures:
  • Wound healing with various topical antimicrobial solutions [ Time Frame: Admission to burn unit to 95% wound healing ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Rate of infections with use of various antimicrobial agents on burn wounds. [ Time Frame: Admission to burn unit to 95% wound healing ] [ Designated as safety issue: No ]
  • Length of hospital stay with various antimicrobial solutions for burn patients [ Time Frame: Admission to burn unit to discharge ] [ Designated as safety issue: No ]

Enrollment: 98
Study Start Date: July 1995
Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Application of Sulfamylon 5% Solution
Drug: Sulfamylon Solution 5%
Application of Sulfamylon Solution to burn wound daily
Other Name: Sulfamylon
Experimental: 2
Application of Dakins 0.025% Solution
Drug: Dakins 0.025% solution
Application of Dakins solution to burn wound daily.
Other Name: Sodium hypochloride
Experimental: 3
Application of Cerium Solution
Drug: Cerium solution
cerium solution applied to burn wounds daily.
Other Name: cerium
Experimental: 4
Application of Silver Nitrate Solution
Drug: Silver Nitrate
Silver Nitrate solution applied to burn wounds daily

  Eligibility

Ages Eligible for Study:   up to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Burn Injury requiring excisional therapy
  • Hospitalization required until wounds are closed

Exclusion Criteria:

  • Known hypersensitivity to products
  • Outpatient treatment for burn injury
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00675922

Locations
United States, Texas
University of Texas Medical Branch
Galveston, Texas, United States, 77555
Sponsors and Collaborators
The University of Texas, Galveston
Investigators
Principal Investigator: David N Herndon, MD University of Texas
  More Information

No publications provided

Responsible Party: The University of Texas, Galveston
ClinicalTrials.gov Identifier: NCT00675922     History of Changes
Other Study ID Numbers: 95-096
Study First Received: December 26, 2007
Last Updated: December 6, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by The University of Texas, Galveston:
Burn
Wounds
Wound infection
Topical antimicrobials
Cerium
Dakins
Sulfamylon Soaks
Silver Nitrate

Additional relevant MeSH terms:
Burns
Wounds and Injuries
Silver Nitrate
Mafenide
Anti-Infective Agents
Anti-Infective Agents, Local
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on February 12, 2012